According to a new report published by Allied Market Research, titled, โRadiodermatitis Market by product, distribution channel, and region: Opportunity Analysis and Industry Forecast, 2019-2027,โ The global radiodermatitis market size was valued at $477.48 million in 2019, and is projected to reach $609.68 million by 2027, registering a CAGR of 4.1% from 2020 to 2027.
The development and severity of radiodermatitis is related to a number of treatment factors such as the total radiation dose, duration of radiotherapy, and treatment with chemotherapy. Furthermore, radiodermatitis can be classified as acute and chronic.
This pandemic has disrupted growth in many economies across various domains. During the COVID-19 pandemic, leading cancer institutions reported that radiotherapy has proved to be the most appropriate and safe treatment option. Whereas, radiation dermatitis is a common side effect of radiotherapy, which can damage skin cells as it fights cancer cells. Hence, demand for radiodermatitis products is anticipated to increase simultaneously, which further boosts growth of the market.
Key Market Players
- The 3m Company
- Bayer Ag.
- Bausch Health Companies Inc.
- Bmg Pharma S.P.A.
- Convatec Group Plc.
- Glaxosmithkline Plc
- Helsinn Healthcare Sa
- Molnlycke Health Care Ab
- Mylan N.V.
- Stratpharma Ag
- Smith & Nephew Plc
Radiodermatitis, also known as radiation dermatitis, is a rare condition caused by radiation therapy for cancer and non-cancer care and has a major negative effect on physical health and quality of life of a patient. In addition, about half of patients undergoing cancer treatment have received radiation therapy during the disease and experienced a degree of skin reaction in almost all of them.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/4498
The development and severity of radiodermatitis is related to a number of treatment factors such as the total radiation dose, duration of radiotherapy, and treatment with chemotherapy. Furthermore, radiodermatitis can be classified as acute and chronic.
Key factors contributing to the growth of the market include the spread of cancer and the increasing adoption of radiotherapy for treatment globally. In addition, the increase in geriatric population further fuels the growth of the radiodermatitis market. The high cost associated with radiodermatitis treatment is expected to curb market growth. In contrast, the increase in demand for reducing the side effects associated with radiation therapy is expected to provide beneficial opportunities for market expansion over the forecast period.
Radiodermatitis, also known as radiation dermatitis, is a rare condition caused by radiation therapy for cancer and non-cancer care and has a major negative effect on physical health and quality of life of a patient. In addition, about half of patients undergoing cancer treatment have received radiation therapy during the disease and experienced a degree of skin reaction in almost all of them.
Key Advantages:
- By product, the topical segment accounted for the largest radiodermatitis market share in 2019.
- By on distribution channel, online pharmacy segment is expected to grow at the highest CAGR during the forecast period
- Asia-Pacific held the major share of the radiodermatitis market at CAGR of 3.3%.
- U.S. accounted for one-fifth share of the global radiodermatitis market in 2019.
Asia-Pacific is estimated to dominate the market throughout the analysis period, owing to the rise in disposable income, increase in expenditure on healthcare, rise in prevalence of cancer patients, and growth in adoption of advanced healthcare products. However, North America is expected to register highest CAGR during the forecast period, owing to inclusion of radiodermatitis products in reimbursement healthcare policy, rise in number of cancer patients, surge in demand for radiation therapy, and high expenditure in the healthcare sector.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ:
Human Growth Hormone (hGH) Market
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐จ๐ง๐ญ๐๐๐ญ:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
Toll Free: 1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com